|
|
|
Info: Your browser does not accept cookies. If you want to put products into your cart and purchase them you need to enable cookies.
Browse
The CRO Market Outlook
This report assesses the drivers and restraints of the global CRO market, highlighting key trends and identifying offshore outsourcing opportunities in fast-growing emerging markets such as China, India and Latin America.
Lipitor Market analysis and forecasts Report
In 2006, Pfizer’s Lipitor (atorvastatin) generated global revenues of $13.6bn, making it the best selling drug in pharmaceutical history. The blockbuster medicine has single-handedly driven the overall revenue margins of the cardiovascular segme
Drug Development Opportunities in China
This report will examine the methods of expansion adopted by China’s pharma companies, biotech developers and CRO’s to increase the scale of their drug development operations, in addition to identifying their therapeutic interests and deve
China Healthcare Sector Analysis
"China Healthcare Sector Analysis" is an exhaustive research by RNCOS on the expanding healthcare market of China. The report provides a detailed account of the factors that define the structure and composition of the healthcare market in Ch
Pharmaceuticals in China
Pharmaceuticals in China industry profile is an essential resource for top-level data and analysis covering the pharmaceuticals industry.
Stakeholder Insight: Hepatitis in China - Liver Let Die?
Hepatitis is a major health problem in China, which is home to one third of hepatitis B patients and one quarter of hepatitis C patients globally. HBV vaccination, together with HBV and HCV screening have helped to reduce transmission, but continued t
Business Opportunities in China: The impact of the WTO
This report discusses the state of the Chinese pharmaceutical industry and the opportunities available to companies doing business in China, and is aimed at individuals in business development and technology transfer looking to expand into China.
Pharma Growth Opportunities in Brazil, Russia, India & China
This report provides an in-depth insight into the competitive dynamics of the BRIC markets. The political and regulatory environments are evaluated and healthcare systems assessed, enabling you to understand the determinants crucial to your success in
Chinese Pharmaceutical Market Overview
The Chinese pharmaceutical market, although only positioned ninth globally, has experienced pronounced and rapid expansion in recent years, driven by the growth of both Chinese and Western manufacturers. Increasingly, there is a shift towards a resear
Results 1 - 11 of 11
|
|
|
|
